1Department of Critical Care Medicine, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA.
2Department of Pediatrics, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA.
3Department of Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA.
4Statistical Analysis and Measurement Consultants, Inc., Lanexa, VA.
5Department of Radiology, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA.
6Department of Emergency Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA.
* See also p. 753.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).
Dr. Fink’s institution received funding from the National Institutes of Health (NIH), Laerdal Foundation, and the University of Pittsburgh Clinical and Translational Science Institute. Dr. Fink received support for article research from the NIH. Dr. Fink is supported by K12 HD047349 from National Institute of Child Health and Human Development, K23 NS065132 from National Institute of Neurological Disorders and Stroke, and the Laerdal Foundation. Dr. Berger is employed by the University of Pittsburgh; provides expert testimony for any civil or criminal court which subpoenas her; received honoraria for giving Grand Rounds and keynote addresses at conferences; receives support for the development of education materials from the PA Department of Public Welfare; and received support for travel (sometimes gives Grand Rounds and other lectures at other institutions and receives reimbursement for travel expenses). Dr. Berger’s institution received grant support from the NIH, PA Department of Public Welfare, and the Casey Foundation and received support for development of educational presentations from PA Department of Public Welfare. Dr. Callaway has patents and royalties with Medtronic ERS, related to timing of defibrillation, licensed to a manufacturer of defibrillators. Dr. Callaway received grant support from the NIH (NIH-U01 Resuscitation Outcomes Consortium; NIH-U01 Neurological Emergencies Treatment Trials) and DoD (Testing and Validation of a Biomedical Detector Device); lectured for Sudden Cardiac Arrest Association, Take Heart America, Society for Critical Care Medicine, St. Mary’s Hospital—Seoul, South Korea, and the Hypothermia and Resuscitation Training Institute; received royalties from patents related to defibrillation; and received support for travel from the American Heart Association. Dr. Callaway’s institution has patent with Medtronic and received royalties from patents related to defibrillation. Dr. Kochanek’s institution received grant support from the NIH and the U.S. Army. Dr. Kochanek is a copatent holder on a biomarker patent to detect child abuse and received support for research from the NIH. Drs. Berger and Kochanek are provisional copatent holders on a biomarker panel for abusive head trauma in infants. This publication was also made possible by 5UL1 RR024153-04 from the National Center for Research Resources (NCRR), a component of the NIH, and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. Information on NCRR is available at http://www.nih.gov/about/almanac/organization/NCRR.htm. Information on Re-engineering the Clinical Research Enterprise can be obtained from http://nihroadmap.nih.gov/clinicalresearch/overview-translational.asp. The remaining authors have disclosed that they do not have any potential conflicts of interest.
For information regarding this article, E-mail: [email protected]
